CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist
  • 26.70
  • +0.04+0.15%
Noon Break Mar 21 11:29 CST
43.41BMarket Cap15.31P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Assets
Current assets
Money funds
-14.25%18.27B
-13.52%17.19B
-22.31%16.23B
-2.43%19.75B
-5.29%21.31B
-8.30%19.87B
-7.37%20.89B
-14.12%20.25B
0.55%22.5B
-9.52%21.67B
Transactional financial assets
----
-75.38%14M
-92.97%4M
-92.97%4M
-92.97%4M
12.24%56.87M
12.24%56.87M
468.73%56.87M
--56.87M
1,166.71%50.67M
Notes receivable and accounts receivable
1.86%16.28B
0.28%17.34B
1.36%17.41B
1.69%17.49B
-0.01%15.98B
5.81%17.3B
9.03%17.18B
13.66%17.2B
13.86%15.98B
14.93%16.35B
-Notes receivable
-36.40%553.92M
-14.58%661.65M
-35.72%689.74M
-37.87%777.48M
-22.75%870.88M
-34.67%774.56M
-15.05%1.07B
-1.13%1.25B
-7.75%1.13B
28.51%1.19B
-Accounts receivable
4.06%15.73B
0.97%16.68B
3.83%16.72B
4.79%16.72B
1.72%15.11B
8.97%16.52B
11.13%16.1B
15.01%15.95B
15.93%14.86B
13.99%15.16B
Other receivables (including interest and dividends)
13.11%993.65M
-9.93%971.41M
18.31%1.06B
-5.44%1.12B
-4.23%878.49M
3.19%1.08B
-18.08%895.1M
-4.76%1.18B
-22.18%917.24M
1.81%1.05B
-Dividend receivable
-97.55%1.5M
-98.57%1.5M
-96.70%1.5M
-72.00%61.26M
-72.00%61.26M
-51.93%105.16M
-86.79%45.4M
-36.36%218.77M
-36.36%218.77M
45.84%218.77M
-Other receivable
21.40%992.15M
----
24.46%1.06B
----
17.00%817.22M
----
13.46%849.7M
----
-16.34%698.48M
----
Advance payment
-29.38%577.94M
-24.42%648.23M
25.01%708.49M
95.23%982.77M
-2.12%818.36M
38.32%857.65M
-8.57%566.75M
-18.08%503.4M
7.29%836.05M
-10.83%620.05M
Inventories
11.34%12.81B
17.46%11.34B
17.34%10.75B
10.10%9.85B
7.83%11.51B
14.43%9.66B
11.85%9.16B
2.45%8.95B
2.24%10.67B
-1.59%8.44B
Receivable financing
-12.13%3.18B
32.20%3.69B
22.97%3.93B
9.02%5.08B
13.56%3.61B
6.86%2.79B
21.81%3.2B
33.68%4.66B
0.34%3.18B
-1.34%2.61B
Non-current assets due within one year
2,274.09%3.78B
207.52%272.58M
-57.64%254.95M
-48.94%283.96M
-75.60%159.36M
-86.31%88.64M
451.75%601.9M
--556.08M
--653.12M
--647.53M
Other current assets
9.16%1.87B
28.96%1.58B
24.88%1.6B
-33.04%1.4B
-24.42%1.71B
-13.98%1.22B
-14.66%1.28B
275.88%2.09B
173.39%2.26B
173.06%1.42B
Total current assets
3.18%57.76B
0.24%53.05B
-3.49%51.94B
0.94%55.96B
-1.89%55.98B
0.13%52.92B
2.54%53.82B
3.92%55.44B
8.05%57.06B
2.35%52.86B
Non Current assets
Debt investment
23.22%8.05B
46.62%9.57B
112.40%9.53B
69.37%6.45B
106.55%6.54B
122.56%6.53B
452.74%4.48B
346.58%3.81B
401.73%3.16B
369.29%2.93B
Other equity investment
0.36%104.18M
-0.67%104.4M
-1.35%104.19M
-5.46%104.48M
-5.26%103.81M
-9.69%105.1M
-15.83%105.62M
-12.34%110.51M
-11.22%109.57M
-27.82%116.38M
Other non-current financial assets
-47.21%531M
89.74%1.02B
-0.56%1.01B
-3.67%1.01B
-3.17%1.01B
-53.93%539.35M
0.32%1.01B
80.12%1.05B
80.89%1.04B
360.69%1.17B
Investment real estate
-14.55%145.07M
11.36%147.66M
10.12%146.78M
-26.58%150.06M
-17.87%169.77M
-36.39%132.6M
-36.36%133.3M
-3.72%204.39M
-3.40%206.71M
-13.58%208.45M
Long-term equity investment
-16.53%1.51B
7.51%1.93B
-1.41%1.8B
23.62%1.83B
13.99%1.81B
8.38%1.79B
12.22%1.83B
-7.48%1.48B
1.36%1.58B
-11.54%1.65B
Fixed assets
26.26%5.53B
----
13.92%4.42B
----
18.08%4.38B
----
11.34%3.88B
----
10.80%3.71B
----
Constru in process
-23.24%1.85B
----
25.06%2.69B
----
14.08%2.41B
----
27.78%2.15B
----
34.80%2.11B
----
Productive biological assets
-46.77%1.12M
-15.93%1.84M
-15.32%1.93M
-14.76%2.02M
-14.23%2.11M
-13.74%2.19M
-13.29%2.28M
-12.86%2.37M
-12.46%2.46M
-12.08%2.54M
Intangible assets
-2.00%2.83B
8.41%2.84B
8.61%2.86B
11.60%2.87B
11.66%2.89B
2.86%2.62B
2.74%2.63B
0.03%2.57B
0.10%2.59B
5.13%2.55B
Development expenditure
19.37%369.93M
38.53%366.38M
37.39%351.78M
31.98%333.02M
28.76%309.89M
1,811.46%264.48M
1,570.14%256.04M
1,832.90%252.33M
2,177.44%240.67M
54.00%13.84M
Goodwill
0.17%830.85M
0.17%830.85M
0.17%830.85M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.00%829.47M
0.47%829.47M
Long deferred expense
-0.69%188.56M
-3.26%188.72M
3.69%184.89M
10.43%185.74M
13.84%189.88M
38.36%195.08M
27.11%178.31M
24.49%168.2M
25.91%166.8M
27.00%141M
Deferred tax assets
4.03%1.21B
24.33%1.17B
10.55%1.22B
33.50%1.19B
34.46%1.16B
15.69%940.69M
32.75%1.1B
12.38%892.5M
8.95%865.34M
5.82%813.13M
Usufruct assets
-22.98%561.41M
-21.03%637.56M
-7.66%676.54M
-9.20%706.32M
-2.83%728.9M
16.50%807.35M
-3.88%732.66M
2.57%777.86M
-2.56%750.16M
-17.26%693.02M
Other non current assets
146.05%212.7M
-54.22%206.17M
-54.05%210.45M
-6.77%212.67M
-63.96%86.45M
104.35%450.33M
112.09%458.04M
4.64%228.13M
42.35%239.83M
14.15%220.37M
Total non current assets
5.83%23.92B
22.29%26.21B
31.55%26.03B
24.82%22.74B
28.42%22.6B
28.36%21.43B
38.26%19.79B
33.02%18.22B
32.27%17.6B
28.99%16.69B
Total assets
3.94%81.68B
6.59%79.26B
5.93%77.97B
6.85%78.7B
5.25%78.59B
6.90%74.35B
10.19%73.61B
9.87%73.66B
12.93%74.67B
7.69%69.55B
Liabilities
Current liabilities
Short term loan
16.98%9.12B
15.36%9.41B
8.14%9.24B
9.98%9.48B
-8.66%7.8B
-3.20%8.16B
-3.96%8.55B
-10.85%8.62B
1.31%8.54B
-7.07%8.43B
Notes payable and accounts payable
4.04%16.32B
1.23%16.35B
1.84%15.29B
4.11%15.14B
4.85%15.69B
6.56%16.15B
12.10%15.01B
6.97%14.54B
1.55%14.96B
9.23%15.15B
-Notes payable
19.27%4.58B
3.54%3.65B
8.92%3.34B
11.58%3.85B
2.22%3.84B
2.66%3.53B
19.67%3.06B
5.78%3.45B
9.13%3.76B
27.16%3.44B
-Accounts payable
-0.90%11.73B
0.58%12.69B
0.03%11.95B
1.78%11.29B
5.73%11.84B
7.70%12.62B
10.31%11.95B
7.35%11.09B
-0.77%11.2B
4.89%11.72B
Contract liabilities
-6.59%5.07B
0.59%1.21B
3.52%1.45B
3.61%1.85B
-3.80%5.43B
4.24%1.2B
18.00%1.4B
17.28%1.78B
105.97%5.64B
-28.49%1.15B
Advance receipts
--4.55M
--5.25M
--5.96M
----
----
----
----
----
----
----
Salaries payable
-15.89%899.11M
-7.91%1.05B
-3.56%1.04B
-2.77%959.68M
5.91%1.07B
16.77%1.14B
13.71%1.08B
13.21%987M
6.25%1.01B
4.34%976.89M
Taxs payable
-35.61%248.91M
-22.87%373.52M
4.99%443.41M
31.41%713.11M
2.89%386.55M
1.23%484.26M
-21.51%422.35M
2.60%542.67M
60.91%375.71M
11.90%478.37M
Other payable (including interest and dividends)
3.15%5.07B
32.01%6.28B
10.18%5.78B
5.31%5.49B
1.75%4.92B
7.58%4.76B
11.09%5.25B
14.12%5.22B
5.63%4.83B
-9.05%4.42B
-Dividend payable
-18.83%50.49M
1,550.82%698.69M
-1.20%213.88M
0.65%54.76M
13.76%62.21M
-22.21%42.32M
5.40%216.47M
0.48%54.41M
-1.99%54.68M
-2.62%54.41M
-Other payable
3.43%5.02B
----
10.67%5.57B
----
1.61%4.86B
----
11.35%5.03B
----
5.73%4.78B
----
Non current liabilities due within one year
509.47%1.52B
306.16%1.44B
-3.93%849.64M
-63.00%253.06M
-64.65%249.83M
-44.34%354.2M
249.45%884.43M
170.77%684.04M
187.52%706.73M
148.81%636.4M
Other current liabilities
-6.35%651.72M
-67.47%144.21M
-66.60%153.79M
-55.11%228.24M
-47.50%695.88M
-39.86%443.24M
-37.79%460.48M
184.56%508.4M
282.99%1.33B
302.13%737.06M
Total current liabilities
7.40%38.92B
10.93%36.26B
3.64%34.25B
3.74%34.12B
-3.10%36.24B
2.19%32.69B
7.73%33.05B
5.44%32.89B
15.94%37.4B
2.46%31.99B
Current liabilities
Long term loan
-15.59%2.81B
-15.57%2.65B
11.72%3.26B
11.90%3.51B
102.76%3.32B
78.84%3.13B
132.97%2.91B
316.63%3.14B
117.74%1.64B
128.16%1.75B
Long term account payable
-1.53%19.67M
----
-3.46%19.67M
----
-2.08%19.97M
----
-0.12%20.37M
----
-0.33%20.4M
----
Long term salaries pay
2.19%299.68K
-1.73%291.83K
-1.01%295.35K
-5.93%293.37K
-7.84%293.26K
-7.83%296.96K
-2.06%298.36K
3.33%311.86K
4.59%318.22K
3.94%322.2K
Estimate liabilities
-21.07%44.14M
4.62%59.35M
30.27%59.39M
26.49%55.7M
17.05%55.93M
27.37%56.73M
1.88%45.59M
-18.28%44.04M
-11.47%47.78M
-37.55%44.54M
Deferred tax liabilities
-2.18%625.56M
39.55%647.36M
1.20%655.99M
60.30%645.87M
62.08%639.53M
31.32%463.9M
84.69%648.18M
16.96%402.9M
18.95%394.59M
14.52%353.26M
Long term deferred income
0.04%1B
7.92%1B
10.47%1.02B
10.13%1.03B
7.57%1B
-5.74%929.99M
-2.32%923.89M
1.47%930.76M
12.59%930.93M
19.21%986.57M
Lease liabilities
-22.91%445.72M
-18.83%512.3M
-6.85%538.16M
-3.48%559.51M
5.93%578.19M
32.47%631.14M
16.25%577.75M
17.14%579.67M
9.67%545.84M
-5.84%476.45M
Other non current liabilities
1.47%55.5M
1.80%54.14M
1.73%54.18M
1.06%54.3M
2.69%54.7M
0.06%53.18M
-1.37%53.26M
-0.91%53.74M
-0.31%53.27M
-2.95%53.15M
Total non current liabilities
-11.91%5B
-6.56%4.94B
8.11%5.6B
13.58%5.87B
56.20%5.67B
43.46%5.29B
63.82%5.18B
95.90%5.17B
43.16%3.63B
44.06%3.69B
Total liabilities
4.78%43.91B
8.49%41.2B
4.24%39.85B
5.08%39.99B
2.15%41.91B
6.46%37.98B
12.97%38.23B
12.50%38.06B
17.93%41.03B
5.61%35.67B
Shareholders equity
Paid-in capital
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
0.00%1.63B
Capital reserve funds
0.08%10.11B
0.08%10.11B
0.08%10.11B
0.00%10.11B
0.00%10.11B
1.49%10.11B
1.49%10.11B
1.49%10.11B
1.49%10.11B
0.73%9.96B
Surplus reserve funds
4.92%2.36B
8.04%2.25B
8.04%2.25B
8.04%2.25B
8.08%2.25B
9.20%2.08B
9.20%2.08B
9.20%2.08B
9.20%2.08B
10.95%1.91B
Retained profit
4.08%21.82B
6.65%22.25B
12.11%22.29B
13.62%22.92B
14.77%20.96B
16.26%20.86B
16.54%19.88B
15.96%20.17B
17.15%18.26B
16.77%17.95B
Other composite income
43.15%-13.84M
-1.45%-19.4M
-45.70%-19.37M
-21.97%-22.91M
-88.70%-24.34M
-129.24%-19.13M
-9.75%-13.29M
-0.97%-18.78M
26.18%-12.9M
56.52%-8.34M
Shareholders equity without minority interests
2.82%35.9B
4.51%36.22B
7.65%36.26B
8.57%36.88B
8.90%34.92B
10.28%34.66B
10.30%33.69B
10.05%33.97B
10.33%32.07B
9.97%31.43B
Minority interests
6.06%1.87B
6.69%1.83B
9.67%1.85B
12.37%1.84B
11.81%1.76B
-29.97%1.72B
-30.15%1.69B
-30.38%1.63B
-30.55%1.57B
9.95%2.45B
Total shareholder equity
2.98%37.77B
4.61%38.05B
7.75%38.12B
8.74%38.71B
9.04%36.68B
7.37%36.38B
7.33%35.38B
7.19%35.6B
7.38%33.64B
9.96%33.88B
Total liabilityies and equity
3.94%81.68B
6.59%79.26B
5.93%77.97B
6.85%78.7B
5.25%78.59B
6.90%74.35B
10.19%73.61B
9.87%73.66B
12.93%74.67B
7.69%69.55B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Assets
Current assets
Money funds -14.25%18.27B-13.52%17.19B-22.31%16.23B-2.43%19.75B-5.29%21.31B-8.30%19.87B-7.37%20.89B-14.12%20.25B0.55%22.5B-9.52%21.67B
Transactional financial assets -----75.38%14M-92.97%4M-92.97%4M-92.97%4M12.24%56.87M12.24%56.87M468.73%56.87M--56.87M1,166.71%50.67M
Notes receivable and accounts receivable 1.86%16.28B0.28%17.34B1.36%17.41B1.69%17.49B-0.01%15.98B5.81%17.3B9.03%17.18B13.66%17.2B13.86%15.98B14.93%16.35B
-Notes receivable -36.40%553.92M-14.58%661.65M-35.72%689.74M-37.87%777.48M-22.75%870.88M-34.67%774.56M-15.05%1.07B-1.13%1.25B-7.75%1.13B28.51%1.19B
-Accounts receivable 4.06%15.73B0.97%16.68B3.83%16.72B4.79%16.72B1.72%15.11B8.97%16.52B11.13%16.1B15.01%15.95B15.93%14.86B13.99%15.16B
Other receivables (including interest and dividends) 13.11%993.65M-9.93%971.41M18.31%1.06B-5.44%1.12B-4.23%878.49M3.19%1.08B-18.08%895.1M-4.76%1.18B-22.18%917.24M1.81%1.05B
-Dividend receivable -97.55%1.5M-98.57%1.5M-96.70%1.5M-72.00%61.26M-72.00%61.26M-51.93%105.16M-86.79%45.4M-36.36%218.77M-36.36%218.77M45.84%218.77M
-Other receivable 21.40%992.15M----24.46%1.06B----17.00%817.22M----13.46%849.7M-----16.34%698.48M----
Advance payment -29.38%577.94M-24.42%648.23M25.01%708.49M95.23%982.77M-2.12%818.36M38.32%857.65M-8.57%566.75M-18.08%503.4M7.29%836.05M-10.83%620.05M
Inventories 11.34%12.81B17.46%11.34B17.34%10.75B10.10%9.85B7.83%11.51B14.43%9.66B11.85%9.16B2.45%8.95B2.24%10.67B-1.59%8.44B
Receivable financing -12.13%3.18B32.20%3.69B22.97%3.93B9.02%5.08B13.56%3.61B6.86%2.79B21.81%3.2B33.68%4.66B0.34%3.18B-1.34%2.61B
Non-current assets due within one year 2,274.09%3.78B207.52%272.58M-57.64%254.95M-48.94%283.96M-75.60%159.36M-86.31%88.64M451.75%601.9M--556.08M--653.12M--647.53M
Other current assets 9.16%1.87B28.96%1.58B24.88%1.6B-33.04%1.4B-24.42%1.71B-13.98%1.22B-14.66%1.28B275.88%2.09B173.39%2.26B173.06%1.42B
Total current assets 3.18%57.76B0.24%53.05B-3.49%51.94B0.94%55.96B-1.89%55.98B0.13%52.92B2.54%53.82B3.92%55.44B8.05%57.06B2.35%52.86B
Non Current assets
Debt investment 23.22%8.05B46.62%9.57B112.40%9.53B69.37%6.45B106.55%6.54B122.56%6.53B452.74%4.48B346.58%3.81B401.73%3.16B369.29%2.93B
Other equity investment 0.36%104.18M-0.67%104.4M-1.35%104.19M-5.46%104.48M-5.26%103.81M-9.69%105.1M-15.83%105.62M-12.34%110.51M-11.22%109.57M-27.82%116.38M
Other non-current financial assets -47.21%531M89.74%1.02B-0.56%1.01B-3.67%1.01B-3.17%1.01B-53.93%539.35M0.32%1.01B80.12%1.05B80.89%1.04B360.69%1.17B
Investment real estate -14.55%145.07M11.36%147.66M10.12%146.78M-26.58%150.06M-17.87%169.77M-36.39%132.6M-36.36%133.3M-3.72%204.39M-3.40%206.71M-13.58%208.45M
Long-term equity investment -16.53%1.51B7.51%1.93B-1.41%1.8B23.62%1.83B13.99%1.81B8.38%1.79B12.22%1.83B-7.48%1.48B1.36%1.58B-11.54%1.65B
Fixed assets 26.26%5.53B----13.92%4.42B----18.08%4.38B----11.34%3.88B----10.80%3.71B----
Constru in process -23.24%1.85B----25.06%2.69B----14.08%2.41B----27.78%2.15B----34.80%2.11B----
Productive biological assets -46.77%1.12M-15.93%1.84M-15.32%1.93M-14.76%2.02M-14.23%2.11M-13.74%2.19M-13.29%2.28M-12.86%2.37M-12.46%2.46M-12.08%2.54M
Intangible assets -2.00%2.83B8.41%2.84B8.61%2.86B11.60%2.87B11.66%2.89B2.86%2.62B2.74%2.63B0.03%2.57B0.10%2.59B5.13%2.55B
Development expenditure 19.37%369.93M38.53%366.38M37.39%351.78M31.98%333.02M28.76%309.89M1,811.46%264.48M1,570.14%256.04M1,832.90%252.33M2,177.44%240.67M54.00%13.84M
Goodwill 0.17%830.85M0.17%830.85M0.17%830.85M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.00%829.47M0.47%829.47M
Long deferred expense -0.69%188.56M-3.26%188.72M3.69%184.89M10.43%185.74M13.84%189.88M38.36%195.08M27.11%178.31M24.49%168.2M25.91%166.8M27.00%141M
Deferred tax assets 4.03%1.21B24.33%1.17B10.55%1.22B33.50%1.19B34.46%1.16B15.69%940.69M32.75%1.1B12.38%892.5M8.95%865.34M5.82%813.13M
Usufruct assets -22.98%561.41M-21.03%637.56M-7.66%676.54M-9.20%706.32M-2.83%728.9M16.50%807.35M-3.88%732.66M2.57%777.86M-2.56%750.16M-17.26%693.02M
Other non current assets 146.05%212.7M-54.22%206.17M-54.05%210.45M-6.77%212.67M-63.96%86.45M104.35%450.33M112.09%458.04M4.64%228.13M42.35%239.83M14.15%220.37M
Total non current assets 5.83%23.92B22.29%26.21B31.55%26.03B24.82%22.74B28.42%22.6B28.36%21.43B38.26%19.79B33.02%18.22B32.27%17.6B28.99%16.69B
Total assets 3.94%81.68B6.59%79.26B5.93%77.97B6.85%78.7B5.25%78.59B6.90%74.35B10.19%73.61B9.87%73.66B12.93%74.67B7.69%69.55B
Liabilities
Current liabilities
Short term loan 16.98%9.12B15.36%9.41B8.14%9.24B9.98%9.48B-8.66%7.8B-3.20%8.16B-3.96%8.55B-10.85%8.62B1.31%8.54B-7.07%8.43B
Notes payable and accounts payable 4.04%16.32B1.23%16.35B1.84%15.29B4.11%15.14B4.85%15.69B6.56%16.15B12.10%15.01B6.97%14.54B1.55%14.96B9.23%15.15B
-Notes payable 19.27%4.58B3.54%3.65B8.92%3.34B11.58%3.85B2.22%3.84B2.66%3.53B19.67%3.06B5.78%3.45B9.13%3.76B27.16%3.44B
-Accounts payable -0.90%11.73B0.58%12.69B0.03%11.95B1.78%11.29B5.73%11.84B7.70%12.62B10.31%11.95B7.35%11.09B-0.77%11.2B4.89%11.72B
Contract liabilities -6.59%5.07B0.59%1.21B3.52%1.45B3.61%1.85B-3.80%5.43B4.24%1.2B18.00%1.4B17.28%1.78B105.97%5.64B-28.49%1.15B
Advance receipts --4.55M--5.25M--5.96M----------------------------
Salaries payable -15.89%899.11M-7.91%1.05B-3.56%1.04B-2.77%959.68M5.91%1.07B16.77%1.14B13.71%1.08B13.21%987M6.25%1.01B4.34%976.89M
Taxs payable -35.61%248.91M-22.87%373.52M4.99%443.41M31.41%713.11M2.89%386.55M1.23%484.26M-21.51%422.35M2.60%542.67M60.91%375.71M11.90%478.37M
Other payable (including interest and dividends) 3.15%5.07B32.01%6.28B10.18%5.78B5.31%5.49B1.75%4.92B7.58%4.76B11.09%5.25B14.12%5.22B5.63%4.83B-9.05%4.42B
-Dividend payable -18.83%50.49M1,550.82%698.69M-1.20%213.88M0.65%54.76M13.76%62.21M-22.21%42.32M5.40%216.47M0.48%54.41M-1.99%54.68M-2.62%54.41M
-Other payable 3.43%5.02B----10.67%5.57B----1.61%4.86B----11.35%5.03B----5.73%4.78B----
Non current liabilities due within one year 509.47%1.52B306.16%1.44B-3.93%849.64M-63.00%253.06M-64.65%249.83M-44.34%354.2M249.45%884.43M170.77%684.04M187.52%706.73M148.81%636.4M
Other current liabilities -6.35%651.72M-67.47%144.21M-66.60%153.79M-55.11%228.24M-47.50%695.88M-39.86%443.24M-37.79%460.48M184.56%508.4M282.99%1.33B302.13%737.06M
Total current liabilities 7.40%38.92B10.93%36.26B3.64%34.25B3.74%34.12B-3.10%36.24B2.19%32.69B7.73%33.05B5.44%32.89B15.94%37.4B2.46%31.99B
Current liabilities
Long term loan -15.59%2.81B-15.57%2.65B11.72%3.26B11.90%3.51B102.76%3.32B78.84%3.13B132.97%2.91B316.63%3.14B117.74%1.64B128.16%1.75B
Long term account payable -1.53%19.67M-----3.46%19.67M-----2.08%19.97M-----0.12%20.37M-----0.33%20.4M----
Long term salaries pay 2.19%299.68K-1.73%291.83K-1.01%295.35K-5.93%293.37K-7.84%293.26K-7.83%296.96K-2.06%298.36K3.33%311.86K4.59%318.22K3.94%322.2K
Estimate liabilities -21.07%44.14M4.62%59.35M30.27%59.39M26.49%55.7M17.05%55.93M27.37%56.73M1.88%45.59M-18.28%44.04M-11.47%47.78M-37.55%44.54M
Deferred tax liabilities -2.18%625.56M39.55%647.36M1.20%655.99M60.30%645.87M62.08%639.53M31.32%463.9M84.69%648.18M16.96%402.9M18.95%394.59M14.52%353.26M
Long term deferred income 0.04%1B7.92%1B10.47%1.02B10.13%1.03B7.57%1B-5.74%929.99M-2.32%923.89M1.47%930.76M12.59%930.93M19.21%986.57M
Lease liabilities -22.91%445.72M-18.83%512.3M-6.85%538.16M-3.48%559.51M5.93%578.19M32.47%631.14M16.25%577.75M17.14%579.67M9.67%545.84M-5.84%476.45M
Other non current liabilities 1.47%55.5M1.80%54.14M1.73%54.18M1.06%54.3M2.69%54.7M0.06%53.18M-1.37%53.26M-0.91%53.74M-0.31%53.27M-2.95%53.15M
Total non current liabilities -11.91%5B-6.56%4.94B8.11%5.6B13.58%5.87B56.20%5.67B43.46%5.29B63.82%5.18B95.90%5.17B43.16%3.63B44.06%3.69B
Total liabilities 4.78%43.91B8.49%41.2B4.24%39.85B5.08%39.99B2.15%41.91B6.46%37.98B12.97%38.23B12.50%38.06B17.93%41.03B5.61%35.67B
Shareholders equity
Paid-in capital 0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B0.00%1.63B
Capital reserve funds 0.08%10.11B0.08%10.11B0.08%10.11B0.00%10.11B0.00%10.11B1.49%10.11B1.49%10.11B1.49%10.11B1.49%10.11B0.73%9.96B
Surplus reserve funds 4.92%2.36B8.04%2.25B8.04%2.25B8.04%2.25B8.08%2.25B9.20%2.08B9.20%2.08B9.20%2.08B9.20%2.08B10.95%1.91B
Retained profit 4.08%21.82B6.65%22.25B12.11%22.29B13.62%22.92B14.77%20.96B16.26%20.86B16.54%19.88B15.96%20.17B17.15%18.26B16.77%17.95B
Other composite income 43.15%-13.84M-1.45%-19.4M-45.70%-19.37M-21.97%-22.91M-88.70%-24.34M-129.24%-19.13M-9.75%-13.29M-0.97%-18.78M26.18%-12.9M56.52%-8.34M
Shareholders equity without minority interests 2.82%35.9B4.51%36.22B7.65%36.26B8.57%36.88B8.90%34.92B10.28%34.66B10.30%33.69B10.05%33.97B10.33%32.07B9.97%31.43B
Minority interests 6.06%1.87B6.69%1.83B9.67%1.85B12.37%1.84B11.81%1.76B-29.97%1.72B-30.15%1.69B-30.38%1.63B-30.55%1.57B9.95%2.45B
Total shareholder equity 2.98%37.77B4.61%38.05B7.75%38.12B8.74%38.71B9.04%36.68B7.37%36.38B7.33%35.38B7.19%35.6B7.38%33.64B9.96%33.88B
Total liabilityies and equity 3.94%81.68B6.59%79.26B5.93%77.97B6.85%78.7B5.25%78.59B6.90%74.35B10.19%73.61B9.87%73.66B12.93%74.67B7.69%69.55B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.